« Brain damage seen in multiple sclerosis patients | Main | Swaziland gripped by double tragedy »

Biogen Idec and Elan to Seek Earlier MS Drug Approval

Biogen Idec Inc. and Elan Corp. said they will apply for U.S. approval of their experimental Antegren multiple sclerosis drug by July, speeding potential clearance of the product by as much as year. Shares of both companies soared.

More here.

February 19, 2004 in antegren , economy, follow the money..., research | Permalink

Comments